NNK-induced hamster lung adenocarcinomas over-express β2- adrenergic and EGFR signaling pathways

Lung Cancer

Volumn 49, Issue 1, 2005, Pages 35-45

  Schuller, Hildegard M ^a   Cekanova, Maria ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

2 Adrenergic; EGFR; NNK hamster

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN; RAF PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL LINEAGE; CLARA CELL; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; HAMSTER; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SMOKING;

ADENOCARCINOMA; ANIMALS; CARCINOGENS; CARCINOMA, NON-SMALL-CELL LUNG; CRICETINAE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MESOCRICETUS; NEOPLASMS, EXPERIMENTAL; NITROSAMINES; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 20444380009     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.12.012     Document Type: Article

References (52)

1. F. Levi, S. Franceschi, C. La Vecchia, L. Randimbison, and V.C. Te Lung carcinoma trends by histologic type in Vaud and Neuchatel, Switzerland, 1974-1994 Cancer 79 1997 906 914
2. A. Kelly, N. Blair, and T.F. Pechacek Women and smoking: issues and opportunities J Womens Health Gend Based Med 10 2001 515 518
3. E.L. Wynder, and J.E. Muscat The changing epidemiology of smoking and lung cancer histology Environ Health Perspect 103 Suppl 8 1995 143 148
4. M.C. Alavanja, R.W. Field, R. Sinha, C.P. Brus, V.L. Shavers, and E.L. Fisher Lung cancer risk and red meat consumption among Iowa women Lung Cancer 34 2001 37 46
5. M.B. Veierod, P. Laake, and D.S. Thelle Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women Eur J Cancer Prev 6 1997 540 549
6. T. Hida, Y. Yatabe, H. Achiwa, H. Muramatsu, K. Kozaki, and S. Nakamura Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas Cancer Res 58 1998 3761 3764
7. K. El-Bayoumy, M. Iatropoulos, S. Amin, D. Hoffmann, and E.L. Wynder Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone: the impact of a high-fat diet Cancer Res 59 1999 1400 1403
8. S.H. Hong, I. Avis, M.D. Vos, A. Martinez, A.M. Treston, and J.L. Mulshine Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors Cancer Res 59 1999 2223 2228
9. F. Lonardo, K.H. Dragnev, S.J. Freemantle, Y. Ma, N. Memoli, and D. Sekula Evidence for the epidermal growth factor receptor as a target for lung cancer prevention Clin Cancer Res 8 2002 54 60
10. M.C. Maa, T.H. Leu, D.J. McCarley, R.C. Schatzman, and S.J. Parsons Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers Proc Natl Acad Sci USA 92 1995 6981 6985
11. L.H. Kuller Dietary fat and chronic diseases: epidemiologic overview J Am Diet Assoc 97 1997 S9 S15
12. L. Eaton Smoking habits of ethnic groups lead to higher risk of heart disease BMJ 328 2004 1397
13. H. Ueshima, S.R. Choudhury, A. Okayama, T. Hayakawa, Y. Kita, and T. Kadowaki Cigarette smoking as a risk factor for stroke death in Japan, NIPPON DATA80 Stroke 2004
14. J.R. Kaplan, and S.B. Manuck Antiatherogenic effects of β-adrenergic blocking agents: theoretical, experimental, and epidemiologic considerations Am Heart J 128 1994 1316 1328
15. D.F. Kong Aspirin in cardiovascular disorders: what is the optimum dose? Am J Cardiovasc Drugs 4 2004 151 158
16. H.M. Schuller, P.K. Tithof, M. Williams, and H. Plummer III The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a β-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via β-adrenergic receptor-mediated release of arachidonic acid Cancer Res 59 1999 4510 4515
17. P.K. Tithof, M. Elgayyar, H.M. Schuller, M. Barnhill, and R. Andrews 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a nicotine derivative, induces apoptosis of endothelial cells Am J Physiol Heart Circ Physiol 281 2001 H1946 H1954
18. H.M. Schuller, B. Porter, and A. Riechert β-Adrenergic modulation of NNK-induced lung carcinogenesis in hamsters J Cancer Res Clin Oncol 126 2000 624 630
19. 2-adrenergic receptor using phosphoserine-specific antibodies Mol Pharmacol 65 2004 196 206
20. G. Wallukat The β-adrenergic receptors Herz 27 2002 683 690
21. L.A. Hu, W. Chen, R.T. Premont, M. Cong, and R.J. Lefkowitz G protein-coupled receptor kinase 5 regulates β 1-adrenergic receptor association with PSD-95 J Biol Chem 277 2002 1607 1613
22. R.J. Lefkowitz The superfamily of heptahelical receptors Nat Cell Biol 2 2000 E133 E136
23. F.U. Muller, P. Boknik, J. Knapp, B. Linck, H. Luss, and J. Neumann Activation and inactivation of cAMP-response element-mediated gene transcription in cardiac myocytes Cardiovasc Res 52 2001 95 102
24. R.B. Pilz, and D.E. Casteel Regulation of gene expression by cyclic GMP Circ Res 93 2003 1034 1046
25. Y. Chen, S. Zhuang, S. Cassenaer, D.E. Casteel, T. Gudi, and G.R. Boss Synergism between calcium and cyclic GMP in cyclic AMP response element-dependent transcriptional regulation requires cooperation between CREB and C/EBP-β Mol Cell Biol 23 2003 4066 4082
26. S. Takeo, M. Niimura, K. Miyake-Takagi, A. Nagakura, T. Fukatsu, and T. Ando A possible mechanism for improvement by a cognition-enhancer nefiracetam of spatial memory function and cAMP-mediated signal transduction system in sustained cerebral ischaemia in rats Br J Pharmacol 138 2003 642 654
27. A. Nagakura, N. Takagi, and S. Takeo Impairment of cerebral cAMP-mediated signal transduction system and of spatial memory function after microsphere embolism in rats Neuroscience 113 2002 519 528
28. V. Gerzanich, S. Ivanova, and J.M. Simard Early pathophysiological changes in cerebral vessels predisposing to stroke Clin Hemorheol Microcirc 29 2003 291 294
29. D. Rosenberg, L. Groussin, E. Jullian, K. Perlemoine, X. Bertagna, and J. Bertherat Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues Ann N Y Acad Sci 968 2002 65 74
30. S.H. Shafer, S.H. Phelps, and C.L. Williams Reduced DNA synthesis and cell viability in small cell lung carcinoma by treatment with cyclic AMP phosphodiesterase inhibitors Biochem Pharmacol 56 1998 1229 1236
31. M. Giorgi, C. Leonetti, G. Citro, and G. Augusti-Tocco In vitro and in vivo inhibition of SK-N-MC neuroblastoma growth using cyclic nucleotide phosphodiesterase inhibitors J Neurooncol 51 2001 25 31
32. B. Wagner, S. Jakobs, M. Habermeyer, F. Hippe, Y.S. Cho-Chung, and G. Eisenbrand 7-Benzylamino-6-chloro-2-piperazino-4-pyrrolidino-pteridine, a potent inhibitor of cAMP-specific phosphodiesterase, enhancing nuclear protein binding to the CRE consensus sequence in human tumour cells Biochem Pharmacol 63 2002 659 668
33. H.M. Schuller, H.P. Witschi, E. Nylen, P.A. Joshi, E. Correa, and K.L. Becker Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone and the modulating effect of hyperoxia Cancer Res 50 1990 1960 1965
34. B.A. Jull, H.K. Plummer III, and H.M. Schuller Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells J Cancer Res Clin Oncol 127 2001 707 717
35. G.V. Scagliotti, G. Selvaggi, S. Novello, and F.R. Hirsch The biology of epidermal growth factor receptor in lung cancer Clin Cancer Res 10 2004 s4227 s4232
36. E.T. Hsieh, F.A. Shepherd, and M.S. Tsao Co-expression of epidermal growth factor receptor and transforming growth factor-alpha is independent of ras mutations in lung adenocarcinoma Lung Cancer 29 2000 151 157
37. A. Budillon, E. Di Gennaro, M. Caraglia, D. Barbarulo, A. Abbruzzese, and P. Tagliaferri 8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor Br J Cancer 81 1999 1134 1141
38. S.A. Belinsky, T.R. Devereux, R.R. Maronpot, G.D. Stoner, and M.W. Anderson Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines Cancer Res 49 1989 5305 5311
39. J. Downward Targeting RAS signalling pathways in cancer therapy Nat Rev Cancer 3 2003 11 22
40. H.G. Gao, J.K. Chen, J. Stewart, B. Song, C. Rayappa, and W.Z. Whong Distribution of p53 and K-ras mutations in human lung cancer tissues Carcinogenesis 18 1997 473 478
41. O. Kovalchuk, W. Naumnik, A. Serwicka, E. Chyczewska, J. Niklinski, and L. Chyczewski K-ras codon 12 mutations may be detected in serum of patients suffering from adeno- and large cell lung carcinoma. A preliminary report Folia Histochem Cytobiol 39 Suppl 2 2001 70 72
42. A.M. Malkinson Molecular comparison of human and mouse pulmonary adenocarcinomas Exp Lung Res 24 1998 541 555
43. V.I. Oreffo, H.W. Lin, R. Padmanabhan, and H. Witschi K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors Carcinogenesis 14 1993 451 455
44. J.P. Pursiheimo, A. Kieksi, M. Jalkanen, and M. Salmivirta Protein kinase A balances the growth factor-induced Ras/ERK signaling FEBS Lett 521 2002 157 164
45. C. Ramstad, V. Sundvold, H.K. Johansen, and T. Lea cAMP-dependent protein kinase (PKA) inhibits T cell activation by phosphorylating ser-43 of raf-1 in the MAPK/ERK pathway Cell Signal 12 2000 557 563
46. S. Maudsley, K.L. Pierce, A.M. Zamah, W.E. Miller, S. Ahn, and Y. Daaka The β(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor J Biol Chem 275 2000 9572 9580
47. K.L. Pierce, L.M. Luttrell, and R.J. Lefkowitz New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades Oncogene 20 2001 1532 1539
48. V.A. Miller, M.G. Kris, N. Shah, J. Patel, C. Azzoli, and J. Comez Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefinitib in advanced non-small-cell lung cancer J Clin Oncol 22 2004 1103 1109
49. D.R. Gandara, H. West, K. Chansky, A.M. Davies, D.H. Lau, and J. Crowley Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition Clin Cancer Res 10 2004 4205 4209
50. H.A. Adissu, and H.M. Schuller Antagonistic growth regulation of cell lines derived from human lung adenocarcinomas of Clara cell and aveolar type II cell lineage: implications for chemoprevention Int J Oncol 24 2004 1467 1472
51. Schuller HM, Al-Wadei HA, Laag E. Chemoprevention of lung cancer: novel challenges and opportunities. In: Proceedings of the 9th World Conference on Advances in Oncology, Crete, Greece; 2004.
52. J.G. Paez, P.A. Janne, J.C. Lee, S. Tracy, H. Greulich, and S. Gabriel EGFR mutations in lung cancer: correlation with clinical response to Gefitinib therapy Science 2004